HIF1A and rheumatoid arthritis: At this point, a tylophorine-based compound reduced inflammation in RAW2.4 cells and meliorated the severity and incidence of collagen monoclonal antibody-induced rheumatoid arthritis in a mouse model by targeting the HIF-1 and c-myc [117].